Project & Orders
Drug Sensitivity Assay for Cancer Stem Cells
ProMab’s drug screening platform relies upon our ability to isolate tumor sphere-forming cancer stem cell populations from primary cancer tissue or cell lines. Cancer stem cell markers allow us to compare parental tumor cell, and cancer stem cells. We also offer many other CSC-related products including cancer stem cell antibodies, cancer stem cell markers and much more.
ProMab Biotechnologies efforts into identifying and subsequent generation of monoclonal antibodies toward, cancer stem cell markers in primary tissues and cells, allows us to offer a unique screening program for novel drugs aimed at a wide range of specific cancer targets.
Cancer Cell lines Available for Testing
Cancer Stem Cell from Primary Tissues
Please contact our scientists for more detail regarding our cancer stem cell drug sensiticity services.